Organigram Implements Protocols and to Take $2.26mm Charge

Visit the OrganiGram Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.

OrganiGramMedicalMarijuana1 (1)
Organigram Completes Investigation and Provides Update on Compensation Policy

MONCTON, NEW BRUNSWICK–(Marketwired – Feb. 27, 2017) – Organigram Holdings Inc. (TSX VENTURE:OGI)(OTCQB:OGRMF) (the “Company”) announces that it has completed the investigation related to a recent contamination issue which resulted in voluntary recalls of medical cannabis products produced by the Company.

Denis Arsenault, Organigram’s Chief Executive Officer, oversaw an extensive investigation that ultimately

... read more at: